SCHEMBL9989300

SCHEMBL9989300

O=S(=O)(Nc1cccc(C(=CO)c2ccnc(Cl)n2)c1)c1c(F)cccc1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC40A1 Q9NP59 2/20 0.39
ALDH1A1 P00352 5/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
PKM P14618 1/20 0.39
BRAF P15056 2/20 0.38
EGFR P00533 1/20 0.38
ERBB2 P04626 1/20 0.38
ERBB3 P21860 1/20 0.38
TEK Q02763 1/20 0.38
ERBB4 Q15303 1/20 0.38
HSD11B1 P28845 1/20 0.37
TBXA2R P21731 1/20 0.35
TBXAS1 P24557 1/20 0.35
GLA P06280 1/20 0.35
PHGDH O43175 1/20 0.34
CYP19A1 P11511 1/20 0.34
PFKFB4 Q16877 1/20 0.33
WDR5 P61964 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1127079 0.80 PKM (0.41) SLC40A1ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL1127074 0.80 PKM (0.41) SLC40A1ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL9988807 0.78 ALDH1A1 (0.45) SLC40A1ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL28427128 0.72 SLC40A1 (0.43) SLC40A1PKMBRAF
SCHEMBL2193388 0.69 SLC40A1 (0.38) SLC40A1ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL2195820 0.67 BRAF (0.56) SLC40A1ALDH1A1MEN1KMT2APKM
SCHEMBL2193968 0.67 LMNA (0.44) ALDH1A1SMN1; SMN2MEN1KMT2ABRAF
SCHEMBL2193965 0.67 LMNA (0.44) ALDH1A1SMN1; SMN2MEN1KMT2ABRAF
SCHEMBL2192293 0.66 BRAF (0.66) BRAFERBB4
SCHEMBL9989917 0.65 SLC40A1 (0.39) SLC40A1ALDH1A1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110319392-A1 Thiazole Sulfonamide And Oxazole Sulfonamide Kinase Inhibitors GLAXOSMITHKLINE LLC 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319392-A1 Thiazole Sulfonamide And Oxazole Sulfonamide Kinase Inhibitors STK24, MAP3K5, MAP3K2 SLC40A1 4661/4885ALDH1A1 2613/4885SMN1; SMN2 2927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.